Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Validea
$12.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cara Therapeutics Inc Files Registration Statement For Proposed Initial Public Offering


Monday, 11 Nov 2013 04:01pm EST 

Cara Therapeutics, Inc announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not been determined. Stifel and Piper Jaffray will act as joint book-running managers for the offering. Canaccord Genuity, Needham & Company and Janney Montgomery Scott will act as co-managers. 

Company Quote

12.44
0.15 +1.22%
30 Jan 2015